BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo W, Vandoorne T, Steyaert J, Staats KA, Van Den Bosch L. The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications. Brain 2020;143:1651-73. [PMID: 32206784 DOI: 10.1093/brain/awaa022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu C, Jiang M, Jiang R, Pang T, Zhang C. The roles of fungus in CNS autoimmune and neurodegeneration disorders. Front Immunol 2023;13. [DOI: 10.3389/fimmu.2022.1077335] [Reference Citation Analysis]
2 Carmela M. The paradigm of amyloid precursor protein in amyotrophic lateral sclerosis: The potential role of the (682)YENPTY(687) motif. Comput Struct Biotechnol J 2023;21:923-30. [PMID: 36698966 DOI: 10.1016/j.csbj.2023.01.008] [Reference Citation Analysis]
3 Khatoon F, Haque S, Hashem A, Mahmoud A, Tashkandi H, Mathkor D, Harakeh S, Alghamdi B, Kumar V. Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer. Front Mol Neurosci 2022;15:1023286. [PMID: 36590916 DOI: 10.3389/fnmol.2022.1023286] [Reference Citation Analysis]
4 Ahmad F, Sachdeva P, Sachdeva B, Singh G, Soni H, Tandon S, Rafeeq MM, Alam MZ, Baeissa HM, Khalid M. Dioxinodehydroeckol: A Potential Neuroprotective Marine Compound Identified by In Silico Screening for the Treatment and Management of Multiple Brain Disorders. Mol Biotechnol 2022. [DOI: 10.1007/s12033-022-00629-3] [Reference Citation Analysis]
5 Lee S, Ryu HG, Kweon SH, Kim H, Park H, Lee KH, Jang SM, Na CH, Kim S, Ko HS. c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation. Cells 2022;11. [PMID: 36552734 DOI: 10.3390/cells11243972] [Reference Citation Analysis]
6 Swaroop RS, Pradhan SS, Darshan VMD, Phalguna KS, Sivaramakrishnan V. Integrated network pharmacology approach shows a potential role of Ginseng catechins and ginsenosides in modulating protein aggregation in Amyotrophic Lateral Sclerosis. 3 Biotech 2022;12:333. [DOI: 10.1007/s13205-022-03401-1] [Reference Citation Analysis]
7 Liao P, Yuan Y, Liu Z, Hou X, Li W, Wen J, Zhang K, Jiao B, Shen L, Jiang H, Guo J, Tang B, Zhang Z, Hu Z, Wang J. Association of variants in the KIF1A gene with amyotrophic lateral sclerosis. Transl Neurodegener 2022;11:46. [PMID: 36284339 DOI: 10.1186/s40035-022-00320-2] [Reference Citation Analysis]
8 Imamura K, Izumi Y, Nagai M, Nishiyama K, Watanabe Y, Hanajima R, Egawa N, Ayaki T, Oki R, Fujita K, Uozumi R, Morinaga A, Hirohashi T, Fujii Y, Yamamoto T, Tatebe H, Tokuda T, Takahashi N, Morita S, Takahashi R, Inoue H. Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial. eClinicalMedicine 2022. [DOI: 10.1016/j.eclinm.2022.101707] [Reference Citation Analysis]
9 Guo W, Wang H, Kumar Tharkeshwar A, Couthouis J, Braems E, Masrori P, Van Schoor E, Fan Y, Ahuja K, Moisse M, Jacquemyn M, Furtado Madeiro da Costa R, Gajjar M, Balusu S, Tricot T, Fumagalli L, Hersmus N, Janky R, Impens F, Vanden Berghe P, Ho R, Thal DR, Vandenberghe R, Hegde ML, Chandran S, De Strooper B, Daelemans D, Van Damme P, Van Den Bosch L, Verfaillie C. CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity. Alzheimers Dement 2022. [PMID: 35993441 DOI: 10.1002/alz.12760] [Reference Citation Analysis]
10 Bassani D, Pavan M, Federico S, Spalluto G, Sturlese M, Moro S. The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? Int J Mol Sci 2022;23:4504. [PMID: 35562894 DOI: 10.3390/ijms23094504] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Seibert K, Smith H, Lapins A, Pytel P, Mastrianni JA. A Novel TBK1 Variant (Lys694del) Presenting With Corticobasal Syndrome in a Family With FTD-ALS Spectrum Diseases: Case Report. Front Neurol 2022;13:826676. [DOI: 10.3389/fneur.2022.826676] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 García-García R, Martín-Herrero L, Blanca-Pariente L, Pérez-Cabello J, Roodveldt C. Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Int J Mol Sci 2021;22:13280. [PMID: 34948077 DOI: 10.3390/ijms222413280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Axtman AD. Characterizing the role of the dark kinome in neurodegenerative disease - A mini review. Biochim Biophys Acta Gen Subj 2021;1865:130014. [PMID: 34547390 DOI: 10.1016/j.bbagen.2021.130014] [Reference Citation Analysis]
14 Sahu R, Upadhayay S, Mehan S. Inhibition of extracellular regulated kinase (ERK)-1/2 signaling pathway in the prevention of ALS: Target inhibitors and influences on neurological dysfunctions. Eur J Cell Biol 2021;100:151179. [PMID: 34560374 DOI: 10.1016/j.ejcb.2021.151179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Wheeler RJ. Therapeutics-how to treat phase separation-associated diseases. Emerg Top Life Sci 2020;4:307-18. [PMID: 32364240 DOI: 10.1042/ETLS20190176] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
16 Bright F, Chan G, van Hummel A, Ittner LM, Ke YD. TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Int J Mol Sci 2021;22:7781. [PMID: 34360544 DOI: 10.3390/ijms22157781] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
17 Benoit I, Brownell S, Douville RN. Predicted Cellular Interactors of the Endogenous Retrovirus-K Integrase Enzyme. Microorganisms 2021;9:1509. [PMID: 34361946 DOI: 10.3390/microorganisms9071509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zech M, Seibt A, Zumbaum B, Klee D, Meitinger T, Winkelmann J, Mayatpepek E, Wagner M, Distelmaier F. MATR3 haploinsufficiency and early-onset neurodegeneration. Brain 2021:awab240. [PMID: 34173818 DOI: 10.1093/brain/awab240] [Reference Citation Analysis]
19 García-Cárceles J, Caballero E, Gil C, Martínez A. Kinase Inhibitors as Underexplored Antiviral Agents. J Med Chem 2021. [PMID: 33970631 DOI: 10.1021/acs.jmedchem.1c00302] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
20 Solomon DA, Smikle R, Reid MJ, Mizielinska S. Altered Phase Separation and Cellular Impact in C9orf72-Linked ALS/FTD. Front Cell Neurosci 2021;15:664151. [PMID: 33967699 DOI: 10.3389/fncel.2021.664151] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
21 Root J, Merino P, Nuckols A, Johnson M, Kukar T. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis 2021;154:105360. [PMID: 33812000 DOI: 10.1016/j.nbd.2021.105360] [Cited by in Crossref: 36] [Cited by in F6Publishing: 45] [Article Influence: 18.0] [Reference Citation Analysis]
22 Wells CI, Al-Ali H, Andrews DM, Asquith CRM, Axtman AD, Dikic I, Ebner D, Ettmayer P, Fischer C, Frederiksen M, Futrell RE, Gray NS, Hatch SB, Knapp S, Lücking U, Michaelides M, Mills CE, Müller S, Owen D, Picado A, Saikatendu KS, Schröder M, Stolz A, Tellechea M, Turunen BJ, Vilar S, Wang J, Zuercher WJ, Willson TM, Drewry DH. The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification. Int J Mol Sci 2021;22:E566. [PMID: 33429995 DOI: 10.3390/ijms22020566] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
23 Palomo V, Nozal V, Rojas-Prats E, Gil C, Martinez A. Protein kinase inhibitors for amyotrophic lateral sclerosis therapy. Br J Pharmacol 2021;178:1316-35. [PMID: 32737989 DOI: 10.1111/bph.15221] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
24 Falcicchia C, Tozzi F, Arancio O, Watterson DM, Origlia N. Involvement of p38 MAPK in Synaptic Function and Dysfunction. Int J Mol Sci 2020;21:E5624. [PMID: 32781522 DOI: 10.3390/ijms21165624] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 12.7] [Reference Citation Analysis]
25 Bean DM, Al-Chalabi A, Dobson RJB, Iacoangeli A. A Knowledge-Based Machine Learning Approach to Gene Prioritisation in Amyotrophic Lateral Sclerosis. Genes (Basel) 2020;11:E668. [PMID: 32575372 DOI: 10.3390/genes11060668] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]